Human CD63 full-length protein presented as virus-like particles (VLPs) is expressed in HEK293 cells. This production method preserves native conformation, post-translational modifications, and orientation in a detergent-free environment. These VLPs exhibit repetitive multivalent display, making them highly immunogenic and suitable for research applications including immunization, antibody discovery, screening, and cell-based assays.
- Expressed from human 293 cells (HEK293)
- Purified to ≥95% purity as determined by SEC-HPLC
- Endotoxin level <1.0 EU per μg by the LAL method
- Stable at -70°C for 12 months under sterile conditions
- Mean peak radius of 55-75 nm with >95% intensity (determined by DLS)
- Supplied as 0.2 μm filtered solution in PBS, arginine, pH 7.4 with trehalose
- Validated for immunization, FACS, and ELISA